Cystic fibrosis: bacterial pathogenesis and CFTR (cystic fibrosis transmembrane conductance regulator) modulators

被引:0
|
作者
Vargas-Roldan, Silvia Y. [1 ,2 ]
Lezana-Fernandez, Jose L. [3 ,4 ]
Cerna-Cortes, Jorge F. [2 ]
Partida-Sanchez, Santiago [5 ,6 ]
Santos-Preciado, Jose, I [1 ]
Rosales-Reyes, Roberto [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Ciudad De Mexico, Mexico
[2] Inst Politecn Nacl, Dept Microbiol, Lab Microbiol Mol, Escuela Nacl Ciencias Biol, Ciudad De Mexico, Mexico
[3] Hosp Infantil Mexico Dr Federico Gomez, Lab Fisiol Respiratoria & Clin Fibrosis Quist, Ciudad De Mexico, Mexico
[4] Assoc Mexicana Fibrosis Quist, Direcc Med, Ciudad De Mexico, Mexico
[5] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Abigail Wexner Res Inst, Columbus, OH USA
[6] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA
来源
BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO | 2022年 / 79卷 / 04期
关键词
Cystic fibrosis; Pseudomonas aeruginosa; Burkholderia cenocepacia; CFTR modulators; VI SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; ADAPTATION; POTENTIATOR; IVACAFTOR;
D O I
10.24875/BMHIM.21000128
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Cystic fibrosis is an autosomal recessive inherited disease caused by mutations in the cystic fibrosis transmembrane con-ductance regulator gene (CFTR). CFTR is a protein that transports ions across the membrane of lung epithelial cells. Loss of its function leads to the production of thick sticky mucus, where various bacterial pathogens can establish and adapt, contributing to the gradual loss of lung function. In this review, evidence of the molecular mechanisms used by Pseudomonas aeruginosa and Burkholderia cenocepacia to survive and persist in the pulmonary environment will be provided. Additionally, new therapeutic strategies based on CFTR function modulators will be described.
引用
收藏
页码:215 / 221
页数:7
相关论文
共 50 条
  • [31] A current review of the safety of cystic fibrosis transmembrane conductance regulator modulators
    Gavioli, Elizabeth Marie
    Guardado, Nerli
    Haniff, Farah
    Deiab, Nouran
    Vider, Etty
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) : 286 - 294
  • [32] Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators
    Burke, Andrew
    Thomson, Rachel M. M.
    Wainwright, Claire E. E.
    Bell, Scott C. C.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 44 (02) : 287 - 296
  • [33] Optimising the care and quality of life of people with cystic fibrosis: the influence of cystic fibrosis transmembrane conductance regulator modulators
    Shaw, Nicola
    Collins, Sarah
    Smith, Thomas
    McCulloch, Anna
    Ketchell, Ian
    Edwards, Viv
    Blaikie, Lesley
    Daniels, Tracey
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2021, 82 (11)
  • [34] Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies
    Carbone, Annalucia
    Vitullo, Pamela
    Di Gioia, Sante
    Conese, Massimo
    GENES, 2023, 14 (10)
  • [35] The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
    Harvey, Caitlyn
    Weldon, Sinead
    Elborn, Stuart
    Downey, Damian G.
    Taggart, Clifford
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [36] Adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: analysis of a national specialty pharmacy database
    Mehta, Zumi
    Kamal, Khalid M.
    Miller, Richard
    Covvey, Jordan R.
    Giannetti, Vincent
    JOURNAL OF DRUG ASSESSMENT, 2021, 10 (01) : 62 - 67
  • [37] Pathogen and autoantigen homologous regions within the cystic fibrosis transmembrane conductance regulator (CFTR) protein suggest an autoimmune treatable component of cystic fibrosis
    Carter, Chris J.
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2011, 62 (02): : 197 - 214
  • [39] Cystic fibrosis transmembrane conductance regulator mutations at a referral center for cystic fibrosis
    de Araujo Correia Coutinho, Cyntia Arivabeni
    de Lima Marson, Fernando Augusto
    Ribeiro, Antonio Fernando
    Ribeiro, Jose Dirceu
    Bertuzzo, Carmen Silvia
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2013, 39 (05) : 555 - 561
  • [40] Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of in Vitro Pharmacology and Clinical Translation
    Ghelani, Drishti P.
    Schneider-Futschik, Elena K.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2020, 3 (01) : 4 - 10